<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Health Policy Trials

descriptionPublicationkeyboard_double_arrow_right Article 01 Jun 2017 English Publisher:Massachusetts Medical SocietyJournal:New England Journal of Medicine, volume 376, pages 2,160-2,167 (issn: 0028-4793, eissn: 1533-4406,

Authors: Joseph P. Newhouse; Sharon-Lise T. Normand;

doi: 10.1056/nejmra1602774

pmid: 28564562

Health Policy Trials

- Summary
- Subjects
- Metrics

Abstract

Trials of various approaches to health insurance and other policy issues can help policymakers decide how to structure incentives to provide the best value. This review examines this type of trial, addressing issues common to and distinct from trials of drugs or devices.

Related Organizations

Harvard University
United States

Keywords

Clinical Trials as Topic, Medically Uninsured, Insurance, Health, Medicaid, Health Policy, Humans, Cost Sharing, Policy Making, United States, Randomized Controlled Trials as Topic

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	22
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%